[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Ethics::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Index






     
 
..
:: Volume 14, Issue 1 And 2 (Spring & summer 2011) ::
EBNESINA 2011, 14(1 And 2): 1-6 Back to browse issues page
The assessment of lorazepam effectiveness to reduce acute and delayed nausea and vomiting among chemotherapy patients: A randomized clinical trial
S.H Molana * , M Afzali , J Emami , M Tajvidi
Abstract:   (12076 Views)
Background: Cancer is defined as one of the most leading causes of death in Iran, as well as the whole world. Chemotherapy as a common modality might have several consequences such as nausea and vomiting. Metoclopramide, anti-5HI3, antagonist and benzodiazepines are used to decrease vomiting symptoms. However, the effectiveness of benzodiazepine is unknown so far. This study aimed to evaluate the role of Lorazepam in decreasing of metoclopramide dosage.
Materials and methods: Seventy consecutive patients were sampled to assess the outcome. Lorazepam was randomly added to premedication drugs in one of two chemotherapy courses for all patients. The lorazepam proscribed one night before chemotherapy and continued for three days after chemotherapy every 12 hours.
Results: The frequency and severity of nausea showed a significant decrease with lorazepam vs. grade II+ acute decrease from 85% to 53% (p<0.0001), grade II+ delayed nausea decrease from 86.2% to 55% (p<0.0001), grade II+ delayed vomiting decrease from 69.14% to 13% (p<0.0001).
Conclusion: Despite previous studies the results of this study show a clear impact of lorazepam benefits on the decrease severity and frequency of nausea and vomiting.
Keywords: Lorazepam, Metoclopramide, Vomiting, nausea Chemotherapy patients
Full-Text [PDF 321 kb]   (3780 Downloads)    
Type of Study: Original |
Received: 2012/05/23 | Accepted: 2014/06/3 | Published: 2014/06/3
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Molana S, Afzali M, Emami J, Tajvidi M. The assessment of lorazepam effectiveness to reduce acute and delayed nausea and vomiting among chemotherapy patients: A randomized clinical trial . EBNESINA 2011; 14 (1 and 2) :1-6
URL: http://ebnesina.ajaums.ac.ir/article-1-122-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 1 And 2 (Spring & summer 2011) Back to browse issues page
ابن سینا EBNESINA
Persian site map - English site map - Created in 0.07 seconds with 39 queries by YEKTAWEB 4645